The vascular perspective on acute and chronic lung disease

The pulmonary vasculature has been frequently overlooked in acute and chronic lung diseases, such as acute respiratory distress syndrome (ARDS), pulmonary fibrosis (PF), and chronic obstructive pulmonary disease (COPD). The primary emphasis in the management of these parenchymal disorders has largel...

Full description

Bibliographic Details
Main Authors: Izabela Borek, Anna Birnhuber, Norbert F. Voelkel, Leigh M. Marsh, Grazyna Kwapiszewska
Format: Article
Language:English
Published: American Society for Clinical Investigation 2023-08-01
Series:The Journal of Clinical Investigation
Online Access:https://doi.org/10.1172/JCI170502
_version_ 1827768128170360832
author Izabela Borek
Anna Birnhuber
Norbert F. Voelkel
Leigh M. Marsh
Grazyna Kwapiszewska
author_facet Izabela Borek
Anna Birnhuber
Norbert F. Voelkel
Leigh M. Marsh
Grazyna Kwapiszewska
author_sort Izabela Borek
collection DOAJ
description The pulmonary vasculature has been frequently overlooked in acute and chronic lung diseases, such as acute respiratory distress syndrome (ARDS), pulmonary fibrosis (PF), and chronic obstructive pulmonary disease (COPD). The primary emphasis in the management of these parenchymal disorders has largely revolved around the injury and aberrant repair of epithelial cells. However, there is increasing evidence that the vascular endothelium plays an active role in the development of acute and chronic lung diseases. The endothelial cell network in the capillary bed and the arterial and venous vessels provides a metabolically highly active barrier that controls the migration of immune cells, regulates vascular tone and permeability, and participates in the remodeling processes. Phenotypically and functionally altered endothelial cells, and remodeled vessels, can be found in acute and chronic lung diseases, although to different degrees, likely because of disease-specific mechanisms. Since vascular remodeling is associated with pulmonary hypertension, which worsens patient outcomes and survival, it is crucial to understand the underlying vascular alterations. In this Review, we describe the current knowledge regarding the role of the pulmonary vasculature in the development and progression of ARDS, PF, and COPD; we also outline future research directions with the hope of facilitating the development of mechanism-based therapies.
first_indexed 2024-03-11T12:08:00Z
format Article
id doaj.art-9f86419b4baa4a8a9a38e9a7a3558ac3
institution Directory Open Access Journal
issn 1558-8238
language English
last_indexed 2024-03-11T12:08:00Z
publishDate 2023-08-01
publisher American Society for Clinical Investigation
record_format Article
series The Journal of Clinical Investigation
spelling doaj.art-9f86419b4baa4a8a9a38e9a7a3558ac32023-11-07T16:20:44ZengAmerican Society for Clinical InvestigationThe Journal of Clinical Investigation1558-82382023-08-0113316The vascular perspective on acute and chronic lung diseaseIzabela BorekAnna BirnhuberNorbert F. VoelkelLeigh M. MarshGrazyna KwapiszewskaThe pulmonary vasculature has been frequently overlooked in acute and chronic lung diseases, such as acute respiratory distress syndrome (ARDS), pulmonary fibrosis (PF), and chronic obstructive pulmonary disease (COPD). The primary emphasis in the management of these parenchymal disorders has largely revolved around the injury and aberrant repair of epithelial cells. However, there is increasing evidence that the vascular endothelium plays an active role in the development of acute and chronic lung diseases. The endothelial cell network in the capillary bed and the arterial and venous vessels provides a metabolically highly active barrier that controls the migration of immune cells, regulates vascular tone and permeability, and participates in the remodeling processes. Phenotypically and functionally altered endothelial cells, and remodeled vessels, can be found in acute and chronic lung diseases, although to different degrees, likely because of disease-specific mechanisms. Since vascular remodeling is associated with pulmonary hypertension, which worsens patient outcomes and survival, it is crucial to understand the underlying vascular alterations. In this Review, we describe the current knowledge regarding the role of the pulmonary vasculature in the development and progression of ARDS, PF, and COPD; we also outline future research directions with the hope of facilitating the development of mechanism-based therapies.https://doi.org/10.1172/JCI170502
spellingShingle Izabela Borek
Anna Birnhuber
Norbert F. Voelkel
Leigh M. Marsh
Grazyna Kwapiszewska
The vascular perspective on acute and chronic lung disease
The Journal of Clinical Investigation
title The vascular perspective on acute and chronic lung disease
title_full The vascular perspective on acute and chronic lung disease
title_fullStr The vascular perspective on acute and chronic lung disease
title_full_unstemmed The vascular perspective on acute and chronic lung disease
title_short The vascular perspective on acute and chronic lung disease
title_sort vascular perspective on acute and chronic lung disease
url https://doi.org/10.1172/JCI170502
work_keys_str_mv AT izabelaborek thevascularperspectiveonacuteandchroniclungdisease
AT annabirnhuber thevascularperspectiveonacuteandchroniclungdisease
AT norbertfvoelkel thevascularperspectiveonacuteandchroniclungdisease
AT leighmmarsh thevascularperspectiveonacuteandchroniclungdisease
AT grazynakwapiszewska thevascularperspectiveonacuteandchroniclungdisease
AT izabelaborek vascularperspectiveonacuteandchroniclungdisease
AT annabirnhuber vascularperspectiveonacuteandchroniclungdisease
AT norbertfvoelkel vascularperspectiveonacuteandchroniclungdisease
AT leighmmarsh vascularperspectiveonacuteandchroniclungdisease
AT grazynakwapiszewska vascularperspectiveonacuteandchroniclungdisease